Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of HBV Therapeutic Vaccine in Consolidation of Nucleos(t)ide Analogues Therapy
NCT02505009Phase 4Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- May 2015
- Primary completion
- Dec 2018
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Hepatitis B vaccine in Chronic Hepatitis B (CHB), sponsored by Chang Gung Memorial Hospital. Primary endpoint: HBV DNA levels. Started May 2015; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02505009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02505009.